Marianna Mariani
Ancona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?
Journal: Frontiers in oncology
Published: August 17, 2020
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis.
Journal: British journal of haematology
Published: July 13, 2020
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: May 13, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
Journal: Journal of bone oncology
Published: March 31, 2020
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype.
Journal: British journal of haematology
Published: February 08, 2016
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes.
Journal: Leukemia
Published: June 20, 2014
Inositol: effects on oocyte quality in patients undergoing ICSI. An open study.
Journal: European review for medical and pharmacological sciences
Published: December 05, 2013
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.
Journal: European journal of haematology
Published: May 13, 2013
Valproic acid for the treatment of low-risk myelodysplastic syndromes: A case report and a review of the literature.
Journal: Leukemia research reports
Published: December 21, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026